- New guidelines from European Society of Endocrinology and the Endocrine Society provide recommendations for managing glucocorticoid-induced adrenal insufficiency during tapering in patients with inflammatory rheumatic diseases.
- Significant risk of adrenal insufficiency during prolonged glucocorticoid therapy highlighted.
- Diagnosis and management of glucocorticoid-induced adrenal insufficiency remain complex.
- Education for both clinicians and patients stressed for recognizing symptoms and implementing preventive measures.
- Further research needed to establish evidence-based protocols for tapering glucocorticoids and monitoring adrenal function.
New Guidelines Tackle Adrenal Insufficiency in GC Tapering
Conexiant
January 27, 2025